gavin
Forum Topics Started
-
- Topic
- Voices
- Last Post
-
- Efficacy of immunotherapy in hepatocholangiocarcinoma (HCC-CC): Proof of concept
- 1
- 3 years, 1 month ago
- Phase II study of lenvatinib in combination with GEMOX chemotherapy for advanced
- 1
- 3 years, 1 month ago
- Molecular alterations, tumor microenvironment and clinical correlations in Thai
- 1
- 3 years, 1 month ago
- Detection of FGFR fusions in intrahepatic cholangiocarcinoma using targeted RNA
- 1
- 3 years, 1 month ago
- Comprehensive molecular characterization of Chinese patients with intrahepatic a
- 1
- 3 years, 1 month ago
- Next Tumor-informed assessment of circulating tumor DNA and its incorporation in
- 1
- 3 years, 1 month ago
- Phase I result of ICP-192 (gunagratinib), a highly selective irreversible FGFR i
- 1
- 3 years, 1 month ago
- Does adjuvant chemoradiation benefit patients with lymph node-positive biliary t
- 1
- 3 years, 1 month ago
- Clinical activity and safety of the RET inhibitor pralsetinib in patients with R
- 1
- 3 years, 1 month ago
- Final results from ClarIDHy, a global, phase 3, randomized, double-blind study o
- 1
- 3 years, 1 month ago
- Gemox chemotherapy in combination with anti-PD1 antibody toripalimab and lenvati
- 1
- 3 years, 1 month ago
- Natural history of patients (pts) with advanced cholangiocarcinoma (CCA) with FG
- 1
- 3 years, 1 month ago
- First-in-human study of highly selective FGFR2 inhibitor, RLY-4008, in patients
- 1
- 3 years, 1 month ago